GLP-1 Pill Rybelsus approved for Type 2
The first GLP-1 agonist pill for Type 2 diabetes has been approved by the European Medicines Agency (EMA). Rybelsus (known as oral semaglutide in clinical trials) is a once-daily
The first GLP-1 agonist pill for Type 2 diabetes has been approved by the European Medicines Agency (EMA). Rybelsus (known as oral semaglutide in clinical trials) is a once-daily
The Ascensia Diabetes Challenge was launched last September. A global innovation competition, it was introduced to fine digital solutions to support Type 2 diabetes management.